Yuanmei Zhu
5PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jul 05, 2022
SARS-CoV-2 fusion-inhibitory lipopeptides maintain high potency against divergent variants of concern including Omicron.Yuanmei Zhu, Xiaojing Dong, Nian Liu
|Nov 25, 2021
Cell membrane-anchored anti-HIV single-chain antibodies and bifunctional inhibitors targeting the gp41 fusion protein: new strategies for HIV gene therapy.Yue Chen, Hongliang Jin, Xiaoran Tang
|May 31, 2021
Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants.Danwei Yu, Yuanmei Zhu, Tao Jiao
|Apr 13, 2021
Pan-coronavirus fusion inhibitors possess potent inhibitory activity against HIV-1, HIV-2, and simian immunodeficiency virus.Danwei Yu, Yuanmei Zhu, Hongxia Yan
|Oct 10, 2020
Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals.Yuanmei Zhu, Danwei Yu, Yang Han
Pageof 1
